The U.S. Food and Drug Administration announced Dec. 20 that it has approved Zepbound (tirzepatide) for the treatment of moderate to severe sleep apnea in adults with obesity to be used ...
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming that the tirzepatide ...
The U.S. Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...
Consolidation within the industry also remained brisk as cost and reimbursement concerns provided acquisition opportunities for large national outfits.
The US Food and Drug Administration has issued a final rule that updates the “healthy” nutrient claim on food labels, ...
Changes are coming to the cold and cough aisle of your local pharmacy: U.S. officials are moving to phase out the leading ...
The U.S. Food and Drug Administration redefined its parameters for “healthy” food for the first time in 30 years.
The FDA has restricted the importation of 11 products from Viatris' Indian facility due to violations of federal requirements ...
With the FDA's new requirements for premarket submission and ongoing monitoring by medical device manufacturers in place, ...
The U.S. Food & Drug Administration (FDA) announced that Lidl recalled all lots of their ‘Taste of Deutschland Buttered Vegetables’ due to undeclared milk allergen.
The US FDA approved Eli Lilly's Zepbound as the first ever medication for obstructive sleep apnea for patients who also have ...
The Food and Drug Administration (FDA) has added a boxed warning about liver injury to fezolinetant (Veozah), a drug often ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback